Use of a recombinant vector encoding il-10 for treating neuropathic pain
CA 2529103 C · Owner: Milligan, Erin · Inventors: Watkins, Linda May Rothblum; Milligan, Erin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described are agents and compositions for use in the treatment of neuropathic pain in a vertebrate subject. Specifically described is a recombinant , vector selected from a replication-defective recombinant virus or a plasmid comprising a polynucleotide comprising a coding sequence for IL-10 operably linked to expression control elements that result in expression of the polynucleotide in vivo. Intrathecal delivery of the recombinant vector is also specifically described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 28, 2004 and granted November 5, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 28, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 28, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.